As pharma companies grapple with the complexities of an evolving healthcare environment, rapidly emerging technologies such as generative AI are unlocking new ways to streamline operations, optimize customer relationships, and unlock new avenues of value for users and customers alike.

In this 90-minute virtual roundtable, led by John Doyle, CTO Life Sciences and Healthcare, Microsoft, Commercial IT decision-makers will gain vital insights into leveraging the power of Generative AI across their customer infrastructure, ultimately leading to more efficient business processes, improved customer relationships, and a significant competitive edge in the pharma industry.

The discussion will commence with a brief introduction to generative AI, providing a broad overview of its principles, functioning, and potential. This segment will help attendees understand generative AI, its divergence from traditional AI approaches, and its potential in the pharmaceutical industry.

Diving deeper, we focus on the potential use cases for Generative AI in enhancing CRM. Through discussion, we will uncover various opportunities and challenges, including predictive modeling, automating customer interactions, enhancing the usability of CRM tools, and facilitating personalized marketing.

By the end of the session, participants will be equipped with knowledge about generative AI’s role in transforming CRM in pharma, empowering them to make informed decisions for their organizations about how best to bring its capabilities into their business and inspire new ways of working.

Seats are limited to 8 participants, so register now to reserve your spot. This virtual roundtable is not broadcast or recorded, so attendees can ask questions and share their own perspectives without concern.